Showing results (91-100 of 360) with videos related to
Sort By:
Pageof 36
Cancer Research|April 1, 1982
Analysis of the fate of systemically administered liposomes and implications for their use in drug deliveryG Poste, C Bucana, A Raz, et al.Journal of Biological Response Modifiers|February 1, 1987
Augmentation of human natural killer cell activity by influenza virus antigens produced in Escherichia coliR C Rees, B J Dalton, J F Young, et al.Trends in Pharmacological Sciences|November 11, 1992
Development of GPIIb/IIIa antagonists as antithrombotic drugsA J Nichols, R R Ruffolo, W F Huffman, et al.Cancer Research|February 1, 1981
The role of plasma membrane receptors and the kinetics of macrophage activation by lymphokines encapsulated in liposomesI J Fidler, A Raz, W E Fogler, et al.Scandinavian Journal of Infectious Diseases|October 24, 2001
Bordetella holmesii bacteraemia in an individual on haemodialysisJ R Greig, S S Gunda, Kwan JTCInternational Journal of Radiation Oncology, Biology, Physics|September 1, 1996
An approach to dose measurement for total body irradiationJ R Greig, R W Miller, P OkunieffFrontiers in Microbiology|November 16, 2020
A Shiga Toxin-Encoding Prophage Recombination Event Confounds the Phylogenetic Relationship Between Two Isolates of Escherichia coli O157:H7 From the Same PatientDavid R Greig, Claire Jenkins, Timothy J DallmanJournal of the American Chemical Society|December 5, 2008
Elucidating the nature of the Streptomyces plicatus beta-hexosaminidase-bound intermediate using ab initio molecular dynamics simulationsIan R Greig, Federico Zahariev, Stephen G WithersThe Laryngoscope|February 19, 2000
Radiation dose to otologic structures during head and neck cancer radiation therapyF G Ondrey, J R Greig, L HerscherCancer Surveys|January 1, 1988
Growth factors as novel therapeutic targets in neoplastic diseaseR Greig, D Dunnington, U Murthy, et al.Pageof 36